News & Updates

Show Multimedia Only
COVID-19 lockdown weakens metabolism in people with glucose intolerance COVID-19 lockdown weakens metabolism in people with glucose intolerance

COVID-19 lockdown weakens metabolism in people with glucose intolerance

10 Sep 2022

In Japan, the declaration of a state of emergency in response to the COVID-19 pandemic led to negative metabolic consequences in people with glucose intolerance, such as lowered skeletal muscle and increased body weight and body fat, a recent study has found.

10 Sep 2022
Trifluridine/tipiracil add-on to bevacizumab safe, effective for mCRC

Trifluridine/tipiracil add-on to bevacizumab safe, effective for mCRC

09 Sep 2022

In patients with metastatic colorectal cancer (mCRC), using trifluridine/tipiracil with bevacizumab is a safe and effective treatment for refractory disease, a recent study has found.

09 Sep 2022
Nine metabolic biomarkers can detect gastric cancer

Nine metabolic biomarkers can detect gastric cancer

09 Sep 2022 byTristan Manalac

Gastric cancer (GC) patients show an altered metabolic profile as compared with healthy individuals, a recent China study has found. A biomarker panel monitoring for nine metabolites can facilitate timely detection of GC.

09 Sep 2022